C12Y 301/11005
Exodeoxyribonuclease v
Official title: Exodeoxyribonuclease V (3.1.11.5)
C12Y301/11005 (Exodeoxyribonuclease v) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 6
- Assignees
- 6
- Inventors
- 17
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 2 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations20 Jan 2026US 12,529,100 B2Roche Sequencing Solutions, Inc.
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations6 Dec 2022US 11,519,026 B2Roche Sequencing Solutions, Inc.
- Enhancement of CRISPR gene editing or target destruction by co-expression of heterologous DNA repair protein27 Sep 2022US 11,453,874 B2The Rockefeller University
- Method of isolating pure mitochondrial DNA16 Jan 2018US 9,868,946 B2Icahn School of Medicine at Mount Sinai
- Kits and methods for quantitative assessment and enrichment of extrachromosomal circular dna26 Dec 2024US 2024/0425910 A1Cedars-Sinai Medical Center
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations9 Mar 2023US 2023/0074210 A1Roche Sequencing Solutions, Inc.
- Enhancement of crispr gene editing or target destruction by co-expression of heterologous dna repair protein7 May 2020US 2020/0140847 A1The Rockefeller University
- Methods for removal of adaptor dimers from nucleic acid sequencing preparations30 May 2019US 2019/0161794 A1Roche Sequencing Solutions, Inc.
- Nucleotide production process11 May 2017US 2017/0130254 A1Nanjing University of Technology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.